PEAK EXPIRATORY FLOW RATE DECREASED side effect
What is PEAK EXPIRATORY FLOW RATE DECREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PEAK EXPIRATORY FLOW RATE DECREASED and Recently Reported Side Effects
PEAK EXPIRATORY FLOW RATE DECREASED and 15 most Active Side Effect polls
PEAK EXPIRATORY FLOW RATE DECREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with PEAK EXPIRATORY FLOW RATE DECREASED
ADVAIR ASMANEX CITALOPRAM FLIXOTIDE FLUTICASONE INTAL PROAIR PULMICORT SALBUTAMOL SYMBICORTSymbicort Side Effects Report #5672995-X
Physician from UNITED STATES reported SYMBICORT problem on Feb 26, 2008. Male patient, weighting 196.0 lb, was diagnosed with asthma and was treated with SYMBICORT. After drug was administered, patient experienced the following problems/side effects: peak expiratory flow rate decreased, . SYMBICORT dosage: unknown. During the same period patient was treated with DILTIAZEM, LIPITOR, SINGULAIR, ALPHAGAN DROP, ALBUTEROL, DUONEB, XALATAN, TESTOSTERONE. Patient recovered.
Intal Side Effects Report #5587935-1
INTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 08, 2007. Female patient was diagnosed with asthma and was treated with INTAL. After drug was administered, patient experienced the following problems/side effects: peak expiratory flow rate decreased, . INTAL dosage: unknown. During the same period patient was treated with ABILIFY, PROPANOLOL, ZOLOFT, WELLBUTRIN, PREMPRO. Patient recovered.
Fluticasone Side Effects Report #5557626-1
Physician from UNITED KINGDOM reported FLUTICASONE PROPIONATE problem on Dec 10, 2007. Male patient, child 8 years of age, was diagnosed with asthma and was treated with FLUTICASONE PROPIONATE. After drug was administered, patient experienced the following problems/side effects: asthma, peak expiratory flow rate decreased, . FLUTICASONE PROPIONATE dosage: unknown. During the same period patient was treated with ALBUTEROL. Patient recovered.
Proair Side Effects Report #5525705-0
PROAIR HFA problem was reported by a Health Professional from UNITED STATES on Nov 20, 2007. Female patient, 23 years of age, weighting 130.0 lb, was diagnosed with asthma and was treated with PROAIR HFA. After drug was administered, patient experienced the following problems/side effects: peak expiratory flow rate decreased, . PROAIR HFA dosage: unknown. During the same period patient was treated with ALBUTEROL, ADVAIR DISKUS, SINGULAIR, PREDNISONE, DESOGEN. Patient recovered.
Advair Side Effects Report #5497163-6
Consumer or non-health professional from UNITED STATES reported ADVAIR DISKUS problem on Jan 17, 2007. Female patient, 83 years of age, weighting 139.3 lb, was diagnosed with bronchiectasis and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, peak expiratory flow rate decreased, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with ALBUTEROL, ZANTAC, FLONASE, MUCINEX, XOPENEX, DIOVAN, DIGITEK, FUROSEMIDE. Patient recovered.
Flixotide Side Effects Report #5771878-4
FLIXOTIDE problem was reported by a Physician from UNITED KINGDOM on June 06, 2008. Male patient, 20 years of age, was diagnosed with asthma and was treated with FLIXOTIDE. After drug was administered, patient experienced the following problems/side effects: asthma, peak expiratory flow rate decreased, . FLIXOTIDE dosage: unknown. During the same period patient was treated with VENTOLIN. Patient recovered.
Pulmicort Side Effects Report #5784327-7
Pharmacist from UNITED STATES reported PULMICORT problem on May 11, 2007. Male patient, 83 years of age, was treated with PULMICORT. After drug was administered, patient experienced the following problems/side effects: peak expiratory flow rate decreased, . PULMICORT dosage: unknown. During the same period patient was treated with UROXATRAL, NASONEX, ANDROGEL, SINGULAIR. Patient recovered.
Citalopram Side Effects Report #5705454-6
CITALOPRAM HYDROBROMIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 31, 2008. Male patient, 30 years of age, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, peak expiratory flow rate decreased, . CITALOPRAM HYDROBROMIDE dosage: 20 MG; ORAL. Patient recovered.
Citalopram Side Effects Report #5710646-6
Health Professional from DENMARK reported CITALOPRAM HYDROBROMIDE problem on Mar 31, 2008. Male patient, 30 years of age, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, peak expiratory flow rate decreased, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. Patient recovered.
Citalopram Side Effects Report #5710841-6
CITALOPRAM HYDROBROMIDE problem was reported by a Health Professional from UNITED KINGDOM on Mar 31, 2008. Male patient, 30 years of age, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, peak expiratory flow rate decreased, . CITALOPRAM HYDROBROMIDE dosage: 20 MG; ORAL. Patient recovered.
Salbutamol Side Effects Report #5747812-X
Physician from UNITED KINGDOM reported SALBUTAMOL SULPHATE problem on May 20, 2008. Male patient, 36 years of age, was diagnosed with asthma and was treated with SALBUTAMOL SULPHATE. After drug was administered, patient experienced the following problems/side effects: asthma, dyspnoea, peak expiratory flow rate decreased, wheezing, . SALBUTAMOL SULPHATE dosage: unknown. During the same period patient was treated with SERETIDE, PREDNISOLONE, STEROIDS, CETIRIZINE. Patient died.
Citalopram Side Effects Report #5706326-3
CITALOPRAM HYDROBROMIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 31, 2008. Male patient, 30 years of age, weighting 154.3 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dyspnoea, peak expiratory flow rate decreased, . CITALOPRAM HYDROBROMIDE dosage: 20 MG, ORAL. Patient recovered.
Asmanex Side Effects Report #5345862-9
Pharmacist from UNITED STATES reported ASMANEX TWISTHALER problem on Jan 25, 2007. Female patient, 57 years of age, weighting 248.0 lb, was diagnosed with asthma and was treated with ASMANEX TWISTHALER. After drug was administered, patient experienced the following problems/side effects: asthma, no therapeutic response, peak expiratory flow rate decreased, . ASMANEX TWISTHALER dosage: unknown. During the same period patient was treated with QVAR. Patient recovered.